Becoming the second drug approved by the U.S. FDA for tenosynovial giant cell tumors, Deciphera Pharmaceuticals Inc.’s oral ...

The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering ...

Immune checkpoint inhibitors (ICIs) have revolutionized the landscape of cancer management. However, acquired resistance and response variability point to rational combination strategies as the goal ...

The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their ...

A study published in Science Advances reveals a novel strategy that allows tumors to evade the body's immune response ...

When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response ...

Scientists have uncovered a mechanism for reinvigorating the immune system to stop it from flagging when it’s fighting ...

1Edwin L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. 2Department of Surgery, Keio ...

Prolonged illnesses like cancer and chronic infections often leave the immune system in a state of exhaustion, where its frontline defenders—T cells—lose their ability to function effectively.

1Jiangxi Key Laboratory of Oncology, JXHC Key Laboratory of Tumor Metastasis, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Jiangxi Cancer Institute, Nanchang, ...

Dana Schulz is an experienced editor, writer, and content strategist who is just as likely to be crunching the ...

Meta says that it is rolling out improvements to Meta AI, its cross-platform chatbot, including the ability to have the bot “remember” details from conversations. In a post on Meta’s ...